{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:06Z","timestamp":1792182306049,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,3,4]],"date-time":"2012-03-04T00:00:00Z","timestamp":1330819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00702-012-0782-2","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T17:12:23Z","timestamp":1330967543000},"page":"1327-1342","source":"Crossref","is-referenced-by-count":11,"title":["Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells"],"prefix":"10.1007","volume":"119","author":[{"given":"Akira","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko S.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyasu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunao","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Nagatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,4]]},"reference":[{"key":"782_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2010.08.011","volume":"125","author":"T Abekawa","year":"2011","unstructured":"Abekawa T, Ito K, Nakagawa S, Nakato Y, Koyama T (2011) Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents. Schizophr Res 125:77\u201387","journal-title":"Schizophr Res"},{"key":"782_CR2","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"DB Allison","year":"1999","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686\u20131696","journal-title":"Am J Psychiatry"},{"key":"782_CR3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(01)03026-8","volume":"923","author":"TD Ardizzone","year":"2001","unstructured":"Ardizzone TD, Bradley RJ, Freeman AM III, Dwyer DS (2001) Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine. Brain Res 923:82\u201390","journal-title":"Brain Res"},{"key":"782_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(95)00292-S","volume":"283","author":"J Arnt","year":"1995","unstructured":"Arnt J (1995) Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine. Eur J Pharmacol 283:55\u201362","journal-title":"Eur J Pharmacol"},{"key":"782_CR5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-009-1551-2","volume":"205","author":"J-M Aubry","year":"2009","unstructured":"Aubry J-M, Schwald M, Ballmann E, Karege F (2009) Early effects of mood stabilizers on the Akt\/GSK-3\u03b2 signaling pathway and on cell survival and proliferation. Psychopharmacology 205:419\u2013429","journal-title":"Psychopharmacology"},{"key":"782_CR6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","volume":"324","author":"RJ Baldessarini","year":"1991","unstructured":"Baldessarini RJ, Frankenburg FR (1991) Clozapine\u2014a novel antipsychotic agent. N Engl J Med 324:746\u2013754","journal-title":"N Engl J Med"},{"key":"782_CR7","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1248\/cpb.36.4377","volume":"36","author":"K Banno","year":"1988","unstructured":"Banno K, Fujioka T, Kikuchi T, Oshiro Y, Hiyama T, Nakagawa K (1988) Studies on 2(1H)-quinolinone derivatives as neuroleptic agents I. Synthesis and biological activities of (4-phenyl-1-piperazinyl)propoxy-2(1H)-quinolinone derivatives. Chem Pharm Bull 36:4377\u20134388","journal-title":"Chem Pharm Bull"},{"key":"782_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/bj3290191","volume":"329","author":"MM Bowker-Kinley","year":"1998","unstructured":"Bowker-Kinley MM, Davis WI, Wu P, Harris RA, Popov KM (1998) Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329:191\u2013196","journal-title":"Biochem J"},{"key":"782_CR9","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1074\/jbc.M806563200","volume":"284","author":"CA Brautigam","year":"2009","unstructured":"Brautigam CA, Wynn RM, Chuang JL, Chuang D (2009) Subunit and catalytic component stoichiometries of an in vitro reconstituted human pyruvate dehydrogenase complex. J Biol Chem 284:13086\u201313098","journal-title":"J Biol Chem"},{"key":"782_CR10","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1007\/s00018-010-0454-z","volume":"67","author":"C Cant\u00f3","year":"2010","unstructured":"Cant\u00f3 C, Auwerx J (2010) AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 67:3407\u20133423","journal-title":"Cell Mol Life Sci"},{"key":"782_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2005.02.072","volume":"1043","author":"C Cosi","year":"2005","unstructured":"Cosi C, Waget A, Rollet K, Tesori V, Newman-Tancredi A (2005) Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. Brain Res 1043:32\u201341","journal-title":"Brain Res"},{"key":"782_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0006-8993(03)02351-5","volume":"971","author":"DS Dwyer","year":"2003","unstructured":"Dwyer DS, Lu XH, Bradley RJ (2003) Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism. Brain Res 971:31\u201339","journal-title":"Brain Res"},{"key":"782_CR13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0003-9861(85)90015-3","volume":"240","author":"JL Gabriel","year":"1985","unstructured":"Gabriel JL, Milner R, Plaut GW (1985) Inhibition and activation of bovine heart NAD-specific isocitrate dehydrogenase by ATP. Arch Biochem Biophys 240:128\u2013134","journal-title":"Arch Biochem Biophys"},{"key":"782_CR14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(75)90135-X","volume":"2","author":"RW Griffith","year":"1975","unstructured":"Griffith RW, Saameli K (1975) Clozapine and agranulocytosis. Lancet 2:657","journal-title":"Lancet"},{"key":"782_CR15","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1073\/pnas.91.23.11012","volume":"91","author":"T Gulick","year":"1994","unstructured":"Gulick T, Cresci S, Caira T, Moore DD, Kelly DP (1994) The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91:11012\u201311016","journal-title":"Proc Natl Acad Sci USA"},{"key":"782_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1432-1033.1997.00259.x","volume":"246","author":"DG Hardie","year":"1997","unstructured":"Hardie DG, Carling D (1997) The AMP-activated protein kinase\u2014fuel gauge of the mammalian cell? Eur J Biochem 246:259\u2013273","journal-title":"Eur J Biochem"},{"key":"782_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-2571(01)00061-9","volume":"42","author":"RA Harris","year":"2002","unstructured":"Harris RA, Bowker-Kinley MM, Huang B, Wu P (2002) Regulation of the activity of the pyruvate dehydrogenase complex. Adv Enzyme Regul 42:249\u2013259","journal-title":"Adv Enzyme Regul"},{"key":"782_CR18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/er.2009-0026","volume":"31","author":"RH Houtkooper","year":"2010","unstructured":"Houtkooper RH, Cant\u00f3 C, Wanders RJ, Auwerx J (2010) Ther secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31:194\u2013223","journal-title":"Endocr Rev"},{"key":"782_CR19","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/hlca.19630460652","volume":"46","author":"F H\u00fcnziker","year":"1963","unstructured":"H\u00fcnziker F, K\u00fcnzle F, Schmutz J (1963) Uber ein 5-Stellung basisch substituierte 5-H Dibenzo [b, e]-1,4-diazepine. Helv Chir Acta 46:2337\u20132346","journal-title":"Helv Chir Acta"},{"key":"782_CR20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3565(25)24408-1","volume":"244","author":"PA Janssen","year":"1988","unstructured":"Janssen PA, Niemegeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF (1988) Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685\u2013693","journal-title":"J Pharmacol Exp Ther"},{"key":"782_CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789\u2013796","journal-title":"Arch Gen Psychiatry"},{"key":"782_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","volume":"274","author":"T Kikuchi","year":"1995","unstructured":"Kikuchi T, Tottori K, Uwahodo Y, Hirose T, Miwa T, Oshiro Y, Morita S (1995) 7-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther 274:329\u2013336","journal-title":"J Pharmacol Exp Ther"},{"key":"782_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245602","volume":"124","author":"BJ Kinon","year":"1996","unstructured":"Kinon BJ, Lieberman JA (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124:2\u201334","journal-title":"Psychopharmacology"},{"key":"782_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2010.10.064","volume":"651","author":"V Koprivica","year":"2011","unstructured":"Koprivica V, Regardie K, Wolff C, Fernalld R, Murphy JJ, Kambayashi J, Kikuchi T, Jordan S (2011) Aripiprazole protects cortical neurons from glutamate toxicity. Eur J Pharmacol 651:73\u201376","journal-title":"Eur J Pharmacol"},{"key":"782_CR25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00702-007-0747-z","volume":"114","author":"S Kurosawa","year":"2007","unstructured":"Kurosawa S, Hashimoto E, Ukai W, Toki S, Saito S, Saito T (2007) Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins. J Neural Transm 114:1121\u20131128","journal-title":"J Neural Transm"},{"key":"782_CR26","doi-asserted-by":"crossref","unstructured":"Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA (1988) Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 247:661\u2013670","DOI":"10.1016\/S0022-3565(25)13416-2"},{"key":"782_CR27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-4547(19990401)56:1<72::AID-JNR9>3.0.CO;2-0","volume":"56","author":"XM Li","year":"1999","unstructured":"Li XM, Chlan-Fourney J, Juorio AV, Bennet VL, Shrikhande S, Keegan DL, Qi J, Boulton AA (1999) Differential effects of Olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor. J Neurosci Res 56:72\u201375","journal-title":"J Neurosci Res"},{"key":"782_CR28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","volume":"60","author":"JA Lieberman","year":"2008","unstructured":"Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG (2008) Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 60:358\u2013403","journal-title":"Pharmacol Rev"},{"key":"782_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2004.03.018","volume":"1011","author":"X-H Lu","year":"2004","unstructured":"Lu X-H, Bradley RJ, Dwyer DS (2004) Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt\/PKB, ERK1\/2, and the mitogen-activated protein kinase. Brain Res 1011:58\u201368","journal-title":"Brain Res"},{"key":"782_CR30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.049","volume":"481","author":"T Matsuo","year":"2010","unstructured":"Matsuo T, Izumi Y, Kume T, Takada-Takatori Y, Sawada H, Akaike A (2010) Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures. Neurosci Lett 481:78\u201381","journal-title":"Neurosci Lett"},{"issue":"Suppl","key":"782_CR31","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","volume":"99","author":"HY Meltzer","year":"1989","unstructured":"Meltzer HY (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99(Suppl):S18\u2013S27","journal-title":"Psychopharmacology"},{"key":"782_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02244925","volume":"112","author":"BM Migler","year":"1993","unstructured":"Migler BM, Warawa EJ, Malick JB (1993) Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug. Psychopharmacology 112:299\u2013307","journal-title":"Psychopharmacology"},{"key":"782_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79\u2013104","journal-title":"Mol Psychiatry"},{"key":"782_CR34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-3565(25)10792-1","volume":"262","author":"NA Moore","year":"1992","unstructured":"Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine, a novel \u201catypical\u201d antipsychotic agent. J Pharmacol Exp Ther 262:545\u2013551","journal-title":"J Pharmacol Exp Ther"},{"key":"782_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","volume":"13","author":"HA Nasrallah","year":"2008","unstructured":"Nasrallah HA (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 13:27\u201335","journal-title":"Mol Psychiatry"},{"key":"782_CR36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/jm940608g","volume":"41","author":"Y Oshiro","year":"1998","unstructured":"Oshiro Y, Sato S, Kurahashi N, Tanaka T, Kikuchi T, Tottori K, Uwahodo Y, Nishi T (1998) Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-Phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives. J Med Chem 41:658\u2013667","journal-title":"J Med Chem"},{"key":"782_CR37","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1440-1681.2002.t01-1-03755.x","volume":"29","author":"M Ota","year":"2002","unstructured":"Ota M, Mori K, Nakashima A, Kaneko YS, Fujiwara K, Itoh M, Nagasaka A, Ota A (2002) Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats. Clin Exp Pharmacol Physiol 29:980\u2013989","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"782_CR38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1440-1681.2005.04184.x","volume":"32","author":"M Ota","year":"2005","unstructured":"Ota M, Mori K, Nakashima A, Kaneko YS, Takahashi H, Ota A (2005a) Resistance to excessive bodyweight gain in risperidone-injected rats. Clin Exp Pharmacol Physiol 32:279\u2013287","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"782_CR39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1163\/156939105774647394","volume":"19","author":"M Ota","year":"2005","unstructured":"Ota M, Mori K, Nakashima A, Kaneko YS, Takami G, Ota A (2005b) mRNA expression levels of leptin-related substances can be modified in risperidone-injected rats. Biog Amines 19:299\u2013308","journal-title":"Biog Amines"},{"key":"782_CR40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neulet.2006.11.018","volume":"412","author":"M Ota","year":"2007","unstructured":"Ota M, Nakashima A, Kaneko YS, Mori K, Takami G, Ota A (2007) Risperidone reduces mRNA expression levels of Sulfonylurea Receptor 1 and TASK1 in PC12 cells. Neurosci Lett 412:254\u2013258","journal-title":"Neurosci Lett"},{"key":"782_CR41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.euroneuro.2008.12.012","volume":"19","author":"SW Park","year":"2009","unstructured":"Park SW, Lee JG, Ha EK, Choi SM, Cho HY, Seo MK, Kim YH (2009) Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells. Eur Neuropsychopharmacol 19:356\u2013362","journal-title":"Eur Neuropsychopharmacol"},{"key":"782_CR42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neures.2011.01.004","volume":"69","author":"SW Park","year":"2011","unstructured":"Park SW, Lee CH, Lee JG, Kim LW, Shin BS, Lee BJ, Kim YH (2011) Protective effects of atypical antipsychotic drugs against MPP+-induced oxidative stress in PC12 cells. Neurosci Res 69:283\u2013290","journal-title":"Neurosci Res"},{"key":"782_CR43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/emm.2001.32","volume":"33","author":"MS Patel","year":"2001","unstructured":"Patel MS, Korotchkina LG (2001) Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases. Exp Mol Med 33:191\u2013197","journal-title":"Exp Mol Med"},{"key":"782_CR44","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1523\/JNEUROSCI.18-15-05575.1998","volume":"18","author":"EN Pothos","year":"1998","unstructured":"Pothos EN, Przedborski S, Davila V, Schmitz Y, Sulzer D (1998) D2-like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci 18:5575\u20135585","journal-title":"J Neurosci"},{"key":"782_CR45","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.102.038083","volume":"303","author":"JC Quinn","year":"2002","unstructured":"Quinn JC, Johnson-Farley NN, Yoon J, Cowen DS (2002) Activation of extracellular-regulated kinase by 5-hydroxytryptamine2A receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J Pharmacol Exp Ther 303:746\u2013752","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"782_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2009.05916.x","volume":"109","author":"GV Ronnett","year":"2009","unstructured":"Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S (2009) AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 109(Suppl 1):17\u201323","journal-title":"J Neurochem"},{"key":"782_CR47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj2630453","volume":"263","author":"GA Rutter","year":"1989","unstructured":"Rutter GA, Denton RM (1989) The binding of Ca2+ ions to pig heart NAD+-isocitrate dehydrogenase and the 2-oxoglutarate dehydrogenase complex. Biochem J 263:453\u2013462","journal-title":"Biochem J"},{"key":"782_CR48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","volume":"425","author":"AW Schmidt","year":"2001","unstructured":"Schmidt AW, Lebel LA, Howard HR Jr, Zorn SH (2001) Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425:197\u2013201","journal-title":"Eur J Pharmacol"},{"key":"782_CR49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)12023-5","volume":"275","author":"TF Seeger","year":"1995","unstructured":"Seeger TF, Seymour PA, Schmidt AW, Zorn SH, Schulz DW, Lebel LA, McLean S, Guanowsky V, Howard HR, Lowe JA III, Heym J (1995) Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther 275:101\u2013113","journal-title":"J Pharmacol Exp Ther"},{"key":"782_CR50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0893-133X(00)00096-8","volume":"23","author":"E Shadach","year":"2000","unstructured":"Shadach E, Gaisler I, Schiller D, Weiner I (2000) The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology 23:151\u2013161","journal-title":"Neuropsychopharmacology"},{"key":"782_CR51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2006.12.005","volume":"414","author":"Y Shen","year":"2007","unstructured":"Shen Y, Fan Y, Dai H, Fu Q, Hu W, Chen Z (2007) Neuroprotective effect of carnosine on necrotic cell death in PC12 cells. Neurosci Lett 414:145\u2013149","journal-title":"Neurosci Lett"},{"key":"782_CR52","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1006\/bbrc.2001.4351","volume":"281","author":"Y Shinohara","year":"2001","unstructured":"Shinohara Y, Daikoku T, Kajimoto K, Shima A, Yamazaki N, Terada H (2001) Expression of NAD+-dependent isocitrate dehydrogenase in brown adipose tissue. Biochem Biophys Res Commun 281:634\u2013638","journal-title":"Biochem Biophys Res Commun"},{"key":"782_CR53","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00702-010-0457-9","volume":"117","author":"G Takami","year":"2010","unstructured":"Takami G, Ota M, Nakashima A, Kaneko YS, Mori K, Nagatsu T, Ota A (2010) Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase. J Neural Transm 117:1139\u20131153","journal-title":"J Neural Transm"},{"key":"782_CR54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","volume":"69","author":"CG Wakade","year":"2002","unstructured":"Wakade CG, Mahadik SP, Waller JL, Chiu F-C (2002) Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res 69:72\u201379","journal-title":"J Neurosci Res"},{"key":"782_CR55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jnr.10668","volume":"73","author":"Z Wei","year":"2003","unstructured":"Wei Z, Bai O, Richardson JS, Mousseau DD, Li X-M (2003) Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. J Neurosci Res 73:364\u2013368","journal-title":"J Neurosci Res"},{"key":"782_CR56","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4088\/JCP.v63n1002","volume":"63","author":"DA Wirshing","year":"2002","unstructured":"Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC (2002) The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 63:856\u2013865","journal-title":"J Clin Psychiatry"},{"key":"782_CR57","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/diabetes.48.8.1593","volume":"48","author":"P Wu","year":"1999","unstructured":"Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, Harris RA (1999) Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48:1593\u20131599","journal-title":"Diabetes"},{"key":"782_CR58","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1016\/S0021-9258(19)39169-0","volume":"265","author":"M Yamada","year":"1990","unstructured":"Yamada M, Amuro N, Goto Y, Okazaki T (1990) Structural organization of the rat cytochrome c oxidase subunit IV gene. J Biol Chem 265:7687\u20137692","journal-title":"J Biol Chem"},{"key":"782_CR59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/syn.20548","volume":"62","author":"TT Yang","year":"2008","unstructured":"Yang TT, Wang SJ (2008) Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia. Synapse 62:804\u2013818","journal-title":"Synapse"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-012-0782-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0782-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T11:09:01Z","timestamp":1742641741000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0782-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,4]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0782-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,4]]}}}